New USP Requirements for Pharmaceutical Packaging Materials and International Standards for the Measurement of Material Permeability Indexes
This year, the USP has already published many new requirements for pharmaceutical packaging systems in the Pharmacopeial Forum (PF). Some of the most important new proposals in the USP are summarized in this news. In addition you can read about recognised standards (ISO, ASTM, etc.) for the testing of permeability properties of packaging materials in this news.
ICH reviews future ICH topics and its Organisation
The results of the International Conference on Harmonisation (ICH) Steering Committee (SC) and its Expert Working Groups (EWGs) meeting in Osaka, Japan have been published. Read more.
Revision of Annex 16: Results of Public Consultation
The responses to the public consultation on the revision of Annex 16 (Certification by a Qualified Person and Batch Release) have been published. Read more.
The European Medicine Agency (EMA) and the U.S. Food and Drug Agency (FDA) have published a joint question-and-answer document that provides further guidance on the quality-by-design concept. Read more.
Revised Annex 16: Comments of the European QP Association
In July this year, the European Commission has published the draft of the new EU-GMP Guideline Annex 16 "Certification by a Qualified Person and Batch Release". The European QP Association has provided a comprehensive summary as feedback to the proposal. Read more.
In a draft for a new General Chapter on "Plastic Materials", the USP has described the requirements set today on plastic packaging materials. It has also defined when plastic materials are suitable for use as packaging systems for medicinal products. Read more details about the publication in the Pharmacopeial Forum.
A huge benefit of smartphones and tablet PCs and apps is that you can access relevant information any time anywhere. Now you can also quickly and comfortably access information with regard to news and regulations in the GMP environment - and more. For that purpose the ECA Foundation took advantage of its longstanding experience to develop a free of charge smartphone and tablet PC WebApp. Find out more....
New FDA Requirements on Labelling and Container Labels
In a new Guideline, the FDA laid down concrete provisions regarding how printed packaging (labels, cartons, etc.) should be designed to ensure the readability of the most important information. The purpose is to enhance the safe use of medicinal products and to reduce the number of medication errors. Read more in the News.
U.S. Government Shutdown: Consequences for the FDA
In the USA federal agencies are facing a government shutdown. But what does that mean for the U.S. Food and Drug Agency FDA? Will inspections be performed? And what about submissions? Read more.
EMA QA Document for the Implementation of the Variations Guidelines
The European Medicines Agency (EMA) has published a document with practical questions and answers to support the implementation of the variations guidelines. Read more.
EMA publishes Concept Paper on the Revision of the Finished Dosage Form Guideline
The EMA has recently published a concept paper on its website that initiates the revision of EMA's Guideline "Note for Guidance on Manufacture of the finished dosage form". Read more here.
Revision of the USP Chapter on Packaging and Storage Requirements
The proposed revision of Chapter <659> on Packaging and Storage Requirements shall help ensuring in the future that the definition of the "single-dose-containers" term is used correctly. In addition, the storage conditions for medicinal products have been defined completely. Read more here in the News.
FDA started Initiative for DUNS Numbers of Pharmaceutical Sites
In one of our last News, we reported about the DUNS numbers for the identification of pharmaceutical sites in Site Master Files. Last year, the FDA also started an initiative for the DUNS numbers. Read more.
Have you ever heard about the Dun and Bradstreet Verification in the EU Site Master File?
With the binding mention of a Site Master File in revised Chapter 4 of the EU GMP Guide, the document has become obligatory for all pharmaceutical companies. The EU Site Master File contains a few essential changes to the previously applicable PIC/S Guideline PE 008-3. In the new version for example under section ... read on.